SCHEMBL8136173

SCHEMBL8136173

CO[C@H]1CN[C@@]1(C)C(=O)Nc1ccc2c(c1)CCN(C(C)C)C2

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TMPRSS2 O15393 2/20 0.36
HRH3 Q9Y5N1 1/20 0.35
MAP3K5 Q99683 2/20 0.34
KDM4E B2RXH2 1/20 0.34
CLK2 P49760 1/20 0.34
CLK3 P49761 1/20 0.34
DYRK1A Q13627 1/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 1/20 0.34
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
NAMPT P43490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8127319 0.87 CLK2 (0.45) TMPRSS2KDM4ECLK2CLK3DYRK1A
SCHEMBL8127514 0.84 KMT2A (0.42) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL8135503 0.83 HRH3 (0.39) TMPRSS2HRH3KDM4EKMT2ASMN1; SMN2
SCHEMBL8132714 0.81 ALDH1A1 (0.42) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL8128276 0.77 MAOA (0.40) KMT2ASMN1; SMN2
SCHEMBL22003804 0.70 ACLY (0.49) HRH3KDM4EALDH1A1NAMPT
SCHEMBL20173801 0.69 KCNA1 (0.47) TMPRSS2KMT2AMEN1NAMPT
SCHEMBL3440779 0.69 CLK2 (0.42) TMPRSS2KDM4ECLK2CLK3DYRK1A
SCHEMBL3879495 0.68 ACACB (0.54) HRH3KDM4EKMT2ASMN1; SMN2GABRA1
SCHEMBL4752371 0.65 CLK2 (0.42) TMPRSS2CLK2CLK3DYRK1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008135525-A2 SUBSTITUTED AZETIDINES, MANUFACTURING AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-11-13 WO disclosed